Sanofi, GSK Restart Trials on COVID-19 Vaccine After Delay

Sanofi and GlaxoSmithKline Plc are restarting a trial of their COVID-19 vaccine, a step forward for a shot that got delayed by a problematic study in the fall. The French drugmaker has corrected the formulation of the shot…